← Research library

Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity.

Animal research · 2016

What was studied
Rat ischemia model and HT-22 cells
Main finding
CPG improved selected neurological and locomotor measures after incomplete global ischemia in rats and protected HT-22 cells against glutamate toxicity.

Study data at a glance

Participants or experimental model
Rat ischemia model and HT-22 cells
Reported results
CPG improved selected neurological and locomotor measures after incomplete global ischemia in rats and protected HT-22 cells against glutamate toxicity.
Study limitations and source details

Study limitations

  • Preclinical findings do not establish human benefit or safety.
  • Abstract only. Full methods and independent replication remain unconfirmed.

Source details

Primary publication metadata and indexed abstract checked via Europe PMC; full methodological review pending.

Abstract reviewed

Sources checked

Citation

Animal / experimentalEnglish abstract

Povarnina PY, Kolyasnikova KN, Nikolaev SV, Antipova TA, Gudasheva TA. Neuropeptide Cycloprolylglycine Exhibits Neuroprotective Activity after Systemic Administration to Rats with Modeled Incomplete Global Ischemia and in In Vitro Modeled Glutamate Neurotoxicity. Bulletin of experimental biology and medicine

Study source ↗ · DOI 10.1007/s10517-016-3241-5 · Bibliography entry · Link to this summary

Related compounds

Editorial policy and evidence standards